The team of Peptisyntha, renowned in therapeutic peptides, is highly skilled in solid and solution phase peptides technologies and is able to provide custom-made peptides from preclinical to commercial scale, applying cGMP production, testing and documentation standards in accordance with the strictest FDA and EMEA requirements. Over decades, Peptisyntha has developed specific know-how in innovative peptide technologies.

Solvay Organics France (SORF), another member of Solvay Organics, has an experience of nearly 30 years in the manufacturing of raw materials, intermediates and APIs for the pharmaceutical industry. The production site, closed to Marseille has the expertise, know-how, capabilities and equipments to develop and produce both your under development and marketed products.  As a professional player in the pharmaceutical industry, the plant operates according to the GMP standards.

Girindus, an independent company member of Solvay Organics, is highly skilled in oligonucleotide technologies and custom synthesis of small molecules for therapeutic use.  Girindus can deliver products for preclinical, clinical and commercial scales, complying with cGMP standards.

Girindus is a company independent of Solvay in which Solvay has a shareholding of 75%